Conclusion
The rapid advance in the development of penicillins and cephalosporins slowed in the mid-1970s, but β-lactams remain the most widely used class of antimicrobial agents. With the emergence of resistance to current antimicrobials, new therapies are sought that offer a long-term solution to the problem of emerging multidrug-resistant clinical isolates. Synthesizing new agents by combining the best features of known classes is an alternative strategy to optimizing the design of existing compounds, and β-lactam structures are versatile, lending themselves to further modifications.
The penems exhibit considerable advantages as a new class of β-lactams: they possess good antibacterial activity against the gram-positive and gram-negative pathogens commonly responsible for a wide range of community infections and are stable to β-lactamases. Developing new antimicrobials remains a challenge, and the penems offer a potential opportunity to meet this continuing need.
The author thanks Chris Thompson for his assistance in preparing the manuscript.
Reprint AddressAddress reprint requests to Jeremy M. T. Hamilton-Miller, D.Sc., FRCPath, Royal Free and University College London Medical School, Royal Free Campus, Rowland Hill Street, London NW3 2PF, United Kingdom; e-mail: j.hamilton-miller@rfc.ucl.ac.uk.
Pharmacotherapy. 2003;23(11) © 2003 Pharmacotherapy Publications
Copyright © 1999, Pharmacotherapy Publications, Inc., All rights reserved.
Comments